ISG15 and breast carcinoma: We therefore assessed MHC class I surface expression on the MDA/LV-control shRNA breast cancer cells constitutively overexpressing ISG15 and MDA/LV-ISG15 shRNA cells silenced for ISG15 expression by the flow cytometry.